|
| ID |
DDInter1572 |
| Drug Type |
small molecule |
| Molecular Formula |
C12H13N |
| Molecular Weight |
171.243
|
| Description |
Rasagiline is an irreversible inhibitor of monoamine oxidase used for the symptomatic management of idiopathic Parkinson's disease as initial monotherapy and as adjunct therapy to levodopa.
|
| ATC Classification |
N04BD02
|
| IUPAC Name |
(1R)-N-(Prop-2-Yn-1-Yl)-2,3-Dihydro-1H-Inden-1-Amine |
| InChI |
Inchi=1S/C12H13N/C1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/H1,3-6,12-13H,7-9H2/T12-/M1/S1 |
| InChI Key |
RUOKEQAAGRXIBM-GFCCVEGCSA-N |
| Canonical SMILES |
C#CCN[C@@H]1CCC2=CC=CC=C12 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|